News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Banks are seeking buyers for construction loans tied to Oracle's data centre expansion.
  • About $56 billion of those loans carry investment-grade ratings backed by future Oracle leases.
  • The leases are linked to a roughly $300 billion arrangement between Oracle and OpenAI.
  • Investment-grade treatment opens the buyer pool to insurers and private credit funds.
  • Oracle plans to raise about $50 billion in 2026 for its data centre rollout.
  • The fundraising push coincides with increased debt issuance among major technology firms.

Latest Articles

TikTok Reaches Settlement with California Plaintiff in Youth Addiction Suit

TikTok Reaches Settlement with California Plaintiff in Youth Addiction Suit

TikTok has settled a lawsuit brought by a 19-year-old California plaintiff, identified in filings as K.G.M., who alleges addiction to social media led to depression and suicidal thoughts. The settlement was disclosed by the plaintiff's lawyer, Joseph VanZandt, as jury selection opened in what had been slated as one of three bellwether trials drawn …

TikTok Reaches Settlement With Teen Plaintiff in Youth Addiction Case Ahead of Trial

TikTok Reaches Settlement With Teen Plaintiff in Youth Addiction Case Ahead of Trial

TikTok has reached an agreement in principle to settle a lawsuit brought by a 19-year-old California plaintiff who says she became addicted to social media platforms and suffered depression and suicidal thoughts as a result. The case, one of three bellwether trials selected from hundreds of related suits, named YouTube, Meta, Snap and TikTok as def…

Nano Labs: A Small-Cap Crypto-Reserve Pivot With A Tactically Bullish Tape

Nano Labs: A Small-Cap Crypto-Reserve Pivot With A Tactically Bullish Tape

Nano Labs is a micro-cap semiconductor design company that has increasingly been framed by the market as a crypto-reserve and Web3 optionality story, anchored around BNB accumulation. With the stock back above key short- and intermediate-term moving averages and MACD in bullish momentum, the trade skews long as long as price holds above the recent …

Dubai Unveils 100 Billion Dirham Plan to Grow Its Financial District

Dubai Unveils 100 Billion Dirham Plan to Grow Its Financial District

Dubai has outlined plans to invest over 100 billion dirhams (about $27 billion) to expand the Dubai International Financial Center. The project, named DIFC Zabeel District, will add 17.7 million square feet to the existing financial hub in a six-phase development scheduled for completion in 2040 as the center works to absorb strong demand from inte…

White House Installs New Lead for Minneapolis Immigration Sweep as Outrage Mounts

White House Installs New Lead for Minneapolis Immigration Sweep as Outrage Mounts

The White House moved to replace a senior Border Patrol official overseeing a high-profile immigration operation in Minneapolis as the administration responded to national anger over the fatal shooting of a U.S. citizen by federal agents. The change, which names Tom Homan to lead the effort in place of Gregory Bovino, accompanies a broader reassess…

BNY Reorganizes Senior Team to Unite Wealth and Managed-Account Businesses

BNY Reorganizes Senior Team to Unite Wealth and Managed-Account Businesses

BNY has reassigned Adam Vos to lead its wealth solutions effort, consolidating BNY Pershing's clearing and custody services - including the Wove platform - with BNY Archer's managed accounts business. The move is part of a broader reshuffle that elevates Jim Crowley to executive vice chair and installs Laide Majiyagbe as global head of markets. The…

BofA Highlights Four Biotech Names Positioned for Potential 2026 Upside

BofA Highlights Four Biotech Names Positioned for Potential 2026 Upside

Bank of America analysts have identified four biotechnology companies they view as top investment ideas for 2026, each supported by specific commercial drivers or upcoming clinical milestones. Their selections - Argenx, KalVista Pharmaceuticals, Ocular Therapeutix and Vertex Pharmaceuticals - carry Buy ratings and price objectives that reflect proj…

Cabaletta Bio: Following the Insider Footsteps Into a High-Short Setup

Cabaletta Bio: Following the Insider Footsteps Into a High-Short Setup

Cabaletta Bio (CABA) is a clinical-stage autoimmune cell therapy name with improving momentum, elevated short interest (about 11 days to cover), and several upcoming clinical and regulatory milestones. With the stock reclaiming key moving averages and still far below its 52-week high, this is a tactically interesting long trade. The setup is not ab…

Oslo OBX Edges Higher as Healthcare, Pharma and Utilities Lead Gains

Oslo OBX Edges Higher as Healthcare, Pharma and Utilities Lead Gains

Norway's benchmark Oslo OBX finished higher on Tuesday, climbing 0.36% as gains in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities supported the market. Cmb.Tech NV led the index's winners and reached a 52-week high, while Nel ASA and other names declined. Commodity and currency markets moved alongside equities, with c…

Tel Aviv benchmark ticks higher as TA-35 closes at fresh record

Tel Aviv benchmark ticks higher as TA-35 closes at fresh record

Israel’s main equity gauge, the TA-35, closed slightly higher Tuesday, reaching a new all-time peak. Gains in biomedical, technology and banking names supported the advance, while a larger number of issues declined than rose. Selected commodities and currency benchmarks moved modestly, with crude and Brent oil up and the US Dollar Index futures low…

Aumovio to Cut Up to 4,000 R&D Roles as It Reins in Costs

Aumovio to Cut Up to 4,000 R&D Roles as It Reins in Costs

Aumovio SE announced plans to eliminate as many as 4,000 research and development positions worldwide as part of a cost-control plan in a challenging market environment. The company said the reductions will be mostly complete by the end of 2026 and will include a voluntary redundancy program in Germany beginning in March. The move accompanies a tar…

SK Telecom Shares Jump on Reappraisal of Anthropic Stake

SK Telecom Shares Jump on Reappraisal of Anthropic Stake

SK Telecom shares climbed sharply after investors recalibrated the worth of the company’s 2023 investment in AI developer Anthropic. The stock gained 12% to reach $26.93, clearing its prior 52-week peak, as analysts and market participants assessed the possible valuation uplift from Anthropic’s rising implied worth and the implications for sharehol…

Morgan Stanley Sticks with Equalweight on Arrowhead, Cites ARO-DIMER-PA Progress and Redemplo Phase 3 as 2026 Catalyst

Morgan Stanley Sticks with Equalweight on Arrowhead, Cites ARO-DIMER-PA Progress and Redemplo Phase 3 as 2026 Catalyst

Morgan Stanley reaffirmed an Equalweight rating and an $81 price target on Arrowhead Pharmaceuticals (ARWR), signaling roughly 19% upside from the current share price of $67.94. The bank highlighted ongoing progress in the ARO-DIMER-PA program and reiterated that Phase 3 SHASTA-3/4 studies of Redemplo (plozasiran) remain the primary 2026 catalyst f…

Omeros Begins Commercial Shipments of YARTEMLEA; Shares Tick Higher

Omeros Begins Commercial Shipments of YARTEMLEA; Shares Tick Higher

Omeros Corporation's stock edged up after the company said it has completed first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors and that transplant centers are beginning to place orders. The therapy, approved by the FDA for adults and children aged two and above, is now being administered to both adult and pediatric patients …